Investors

Investor Relations

Medication nonadherence is a critical challenge, costing the industry
hundreds of billions of dollars a year and negatively impacting count-
less patient lives.

At Adheris, we’re partnering with leading pharma companies and
pharmacy retailers to tackle this issue head-on through the delivery of
patient engagement solutions that leverage pharmacy and longitudinal
pharmacy data at scale, and advanced sequencing to tailor communi-
cations to individual patients.

Share Registrar

Computershare Investor Services Pty Ltd
Ph: 1300 850 505 (within Australia)
+613 9415 4000 (outside Australia)

Latest Stock Info

 
FILTER BY:
Year
Type
Search

ASX Announcements

Date Title Download
Download
Showing - of
FILTER BY:
Year
Search

EGM & AGM Announcements

ASX Announcements
Date Title Download
Download
Showing - of

Reports & Presentations

2024

2024 Annual Report

2024

2024 Annual Webinar Presentation

2024

2024 Half-yearly Report

2024

2024 Half-yearly Presentation

2023

2023 Annual Report

2023

2023 Half-yearly Report

2023

2023 Annual Webinar Presentation

2023

2023 Half-yearly Presentation

2025

2026 Q1 Investor Presentation

2025

2025 MDR Half Year Report and App 4D

2025

2025 MDR Annual Report

2025

2025 Annual General Meeting

2026

2026 Investor Roadshow Presentation

2026

2026 Extraordinary General Meeting

2026

2026 Q3 FY26 Results

2026

12 March 2026, Extraordinary General Meeting

2025

2025 Annual General Meeting | Report & Presentation

2025

26 Nov 2025, Annual General Meeting | Webinar

Webinars

2025

26 Nov 2025, Annual General Meeting

2026

12 March 2026, Extraordinary General Meeting

2026

29 April 2026, Q3 FY26 Results Presentation

2025

22 Oct 2025, 1Q FY26 Investor Update

2025

8 July 2025, MedAdvisor Investor Update

2025

30 April 2025, FY25 3Q Update

2023

7 Sept 2023, FY23 Results

2024

29 Aug 2024, FY24 Results

2024

20 Dec 2024, Investor Briefing

Corporate Governance

Audit and Risk Committee Charter

Board Charter

People, Remuneration and Nominations Committee Charter

Anti-Bribery and Corruption Policy

Continuous Disclosure Policy

Diversity and Inclusion Policy

Securities Trading Policy

Shareholder Communication Policy

Whistleblower Policy

Corporate Governance Statement 2024

Code of Conduct

Constitution

Conflict of Interest

Load More